Embed code
Note: this content has been automatically generated.
00:00:06
um so today i'll be talking to rouse solutions that the file
00:00:10
and what we want to be in what we aim to be is a fully independent solution
00:00:16
that's it's within the health economy to facilitate the shift value
00:00:21
based health care and improves aside the well being
00:00:24
we are trying to develop a global solution um and we have a
00:00:30
partnership with swiss calm while our technical and developmental partners to provide
00:00:36
us with the ball chain development will uh also joining the action checkup
00:00:41
and we also have some numerous uh industry partnerships as well
00:00:47
um so i'm i'm sure with the healthcare background y'all have you're all aware
00:00:52
of some of the main problems you know facing societies as a whole
00:00:57
health care yeah is faced with on sustainable expenditure and this is due to eighteen populations
00:01:04
rising prevalence of of chronic diseases and rising treatment costs
00:01:09
and we also see that healthcare is moving towards personalisation like the previous presenter has said
00:01:16
and this is resulted in in a barrier to market access for manufacturers for the innovative therapies
00:01:23
we see health authorities in shores can't afford to pay for these new high
00:01:28
cost therapies this also results in barriers to access for patients as well
00:01:34
so patients often the night these lifesaving therapies well they have to pay for therapies
00:01:40
it doesn't work and we see that this is quite an unfair system
00:01:47
and we see the who well there's moving forward value based health care and value
00:01:50
based uh health deals of being struck internationally of the last few years
00:01:57
let's take one example metro naked zero value basically isn't two thousand seventeen
00:02:02
in two thousand eighteen they have more than a thousand the like to estimate that more
00:02:07
than seventy five percent of health care payments by twenty twenty will be value based
00:02:14
and what is value based healthcare value based half k. is paying for performance
00:02:19
and no longer pay in for service or paying for volume
00:02:23
so we only pay the full price if the treatment gives good patient outcomes
00:02:31
but one of the main problems with we see with value based health
00:02:34
care and value based pricing is the infrastructure limitations of actually
00:02:39
implementing this and this is the main problem that we seek to
00:02:44
solve so some of the key problems is trusting transparency
00:02:49
because payment for health care is now based on outcomes it's all about
00:02:54
what the results of the treatments are these can easily be manipulated
00:02:58
by either party and this is one problem we currently see
00:03:02
there's also the privacy and security of these pricing agreements the administrative burden that's associated with
00:03:09
tracking patience patience start treatments at different times they reach different events in different times
00:03:16
and combining these with different pricing agreement as well the re conciliation is
00:03:21
it's quite a big administrative bit than an essentially the costs of doing this
00:03:26
negates all the cost benefit of actually moving to a value based approach
00:03:33
what we also see our technical limitations so the ability to follow patients as
00:03:39
they move across different treatment centres we also have issues with time delays
00:03:45
of reimbursement because of this currently in some countries
00:03:50
uh let's take i learned for example last year hepatitis c. patients were not able to get
00:03:56
treatment for a period of six to eight weeks 'cause there's a rebate mechanism in place
00:04:01
where at a manufacturer will hold a funds that they given by the player
00:04:07
until the outcomes are completely check through in the fine and then that a
00:04:12
discount or or refund the sent back and this is an unsustainable model
00:04:17
and we also see that there is no one single platform that anybody can use
00:04:22
so what did you farm we utilise blocking technology to create
00:04:26
that data integrity and a mute ability around outcomes
00:04:30
so everybody knows that this is the one true vision of events and
00:04:34
everybody within that network has a copy of of that uh data
00:04:41
we also understand that privacy and security of
00:04:45
pricing agreements is is key essentially
00:04:49
clinical trials data yes that's confidential but essential that that
00:04:52
that's always published into the public domain where
00:04:55
is next prices and discounts uh i things that the never essentially released into the public
00:05:02
and so we use private permission block chains well only those
00:05:06
actors within that network have access to that data
00:05:11
we also eliminated ministry to bit in using smart contract
00:05:15
so smart contracts a digital representations of physical
00:05:18
contracts well we can entities pricing agreements
00:05:21
and these are able to be executed automatically according to the data systems that these link
00:05:27
to so in healthcare this would be health information system or clinical data registry
00:05:33
we also use digital identities and not be spoke integration engines to be
00:05:37
able to track patients across different treatment centres and because combining all
00:05:43
of this were able to create is real time reinvestment in settlement
00:05:47
mechanisms on we're able to create this one single global platform
00:05:51
for farmer company they can use in every country day trying to gain access to and for
00:05:55
pay or they can use that to every manufacturer provider they have value based agreements with
00:06:03
so one of our flagship solutions is the real based platform and taking all that
00:06:08
i've said into account you can now create very complex and personalise pricing agreements
00:06:14
whether it's a price agreement for an oncology drug that's based on survival
00:06:18
well whether it's an agreement that include survival the serious adverse events of interest
00:06:24
a re hospital association rate or any other surrogate endpoint that's collected by some sort
00:06:29
of digital device no matter how many conditions you place in this agreement
00:06:34
the administrative been does not change and this is something that we see
00:06:38
is very important so we've set up our system to be fully
00:06:46
flexible fully customisable to work within any type of healthcare system whether
00:06:51
to single payer system like the u. k. n. h. s.
00:06:55
whether it's a and and uh but don't think shows base system like we seen sweets and
00:07:00
well we can also look at 'em systems where patients but don t. pay for their house cat
00:07:06
outright with out of pocket payments i i and this is an example of a manufacturer dashboard
00:07:14
so many factors and and anybody within the network is able to customise these platforms and
00:07:20
include the key performance indicators how they wish and we have certain access management facilities
00:07:26
so only for example if you are not pharmaceutical company only the the the pricing
00:07:32
team or the health economics team will be able to see this pricing
00:07:35
data rows of the you know clinical departments can actually see key product performance
00:07:40
and the other indicators so in regards to lodge any so far
00:07:46
um we have many pilots in planning with several international health authorities
00:07:54
um cross three conference continents um and we're in negotiations and discussions with certain pilots
00:08:01
what ate up the top ten pharmaceutical companies were also reaching it
00:08:05
to work with a community care providers and social care
00:08:08
as we see value based commissioning in that area is huge as essentially
00:08:13
eh in community can social care outcomes and not being tracked and these
00:08:18
are populations especially the elderly that have the highest cost within
00:08:23
uh for health systems uh and we're also working with
00:08:26
channel mic sequencing partners to get patients to participate
00:08:31
on some of our platforms to receive three gentlemen profiling i'll get that get to that later
00:08:38
i'm sorry lost our road map uprising platform will be ready within the next
00:08:42
four weeks ready to kick off pilots but the minimum bible network
00:08:48
um we hope to have three very significant large
00:08:52
scale pilots with the minimum bible network
00:08:55
uh by the end of two thought so completed by the end of two thousand
00:08:59
nineteen and a minimum bible network is is those for example uh uh pay a manufacturer
00:09:05
and uh provide that we'll have a series of smaller pilots when we need
00:09:10
um and we seek to have an international roll out by early two thousand nineteen as we are the first independent
00:09:17
a pricing platform uh on the market at the moment i so because we are able to
00:09:24
integrate and link into sits in health information systems
00:09:28
we want to provide patients you opportunity
00:09:32
to be rewarded for sharing their health data and create a real well evidence database
00:09:39
um and this is a database that will be actors repository for global
00:09:44
data and this is something that's currently missing in health care
00:09:49
um hum and through that we also want to create the did you have platform 'cause this is
00:09:57
the actual application where patients can actually manage their
00:10:01
data they can give access to whatever organisations
00:10:04
the uh you know they would they wish to um patients with with some
00:10:10
of this uh data that's in the monster data for red diseases
00:10:14
if that date is accessed more than these uh patience will be
00:10:17
rewarded more as well so we're creating these digital nuggets essentially
00:10:21
and way using the block chain to be able to track our
00:10:25
g. d. p. r. compliance as well to see where this data is being used who's looked at it
00:10:31
um and also using that as a mechanism for regime as well
00:10:37
this is also platform where patients can be identified by organisations
00:10:43
who seek to a recruit them for a clinical
00:10:46
research studies one additional platform we have is a a
00:10:51
platform pulled of all four crowd funding innovations so
00:10:54
digital asset position and talk in isolation using watching technology to a really effort trot funding value
00:11:01
medical innovation so giving people the public the opportunity to invest in early half technology
00:11:08
and giving a these organisations to receive money quite easily to develop
00:11:13
their products if um and that's it uh thank you
00:11:24
i think you know the question only one
00:11:30
okay willow a ticket from of people and it was big and uh one question
00:11:38
but if you're gonna an important one though it's the the dipper are related
00:11:42
those so used to those some bucks that's in contradictory the
00:11:47
uh with the real to deploy or or buttons
00:11:49
the blue blue's will be a little more or expose it on how exactly
00:11:53
alluded bread compliant but integrating a pageant uh that uh for instance
00:11:59
and the um cody room sure go right to the blue forgotten in regards to which platform to to
00:12:06
your or probably proposal to room norman probably pop proposal
00:12:10
so our main product proposals the pricing platform
00:12:13
and within g. d. p. all the special section for paying for health care um and essentially
00:12:19
the data we poll is essentially all anonymous anyway um so that i sort anonymous
00:12:41
um well i mean to be honest i mean anonymous anonymous them under the way i say it
00:12:45
is essentially the same but that's with the technical teams will do it right i mean
00:12:49
what we need a a a for for paying for health care i mean you don't
00:12:56
need the patient id to pay for the health care we're creating the digital tag
00:13:01
to the certain fields so we can use utilise in utilise nation data and things like that
00:13:07
and also when you start aggregate think data as well then this
00:13:10
ways to actually um use that to paying for health care
00:13:19
yeah no i mean them so that the innate no no i understand understand so we sent to we don't hold
00:13:26
any of this data on the block chain or anything like this this is all held off chain as well
00:13:30
and we have the block chain hold hash is which point to where the status as essentially help
00:13:37
it is a lot less that would get your it you look us dollars
00:13:40
though we don't normal okay so thank you all for the presentation

Share this talk: 


Conference program

Mots de bienvenue
Sébastien Mabillard, CEO | Swiss Digital Health
15 June 2018 · 9:07 a.m.
Mots de bienvenue
Victor Fournier, Chef de Service de la santé publique | Canton du Valais
15 June 2018 · 9:11 a.m.
Mots de bienvenue
Jean-Albert Ferrez, Président | Fondation The Ark
15 June 2018 · 9:19 a.m.
Mots de bienvenue
Laurent Sciboz, directeur Institut Informatique de Gestion | HES-SO Valais/Wallis
15 June 2018 · 9:24 a.m.
L'écosystème d'innovation ouverte du CHU Sainte-Justine: une grande communauté gagnante!
Kathy Malas, resp. de la Plateforme de l’innovation et des Fonctions des maladies chroniques et aiguës | CHU SAINTE-JUSTINE (Canada)
15 June 2018 · 9:33 a.m.
Les livraisons par drones : vers une amélioration de la logistique dans le domaine médical
Janick Mischler, Program Manager | LA POSTE SUISSE
15 June 2018 · 10:07 a.m.
E-health et intégration des soins
Marc Cikes, CEO | MEDBASE ROMANDIE (Suisse)
15 June 2018 · 10:32 a.m.
Questions réponses
Remi Gauchoux, Business Development Director - Carenity
15 June 2018 · 11:46 a.m.
Futur de la santé mobile
Dr. med. Patricia Sigam, CEO & Co-founder, digital Med-Lab
15 June 2018 · 11:54 a.m.
Democratizing Data-Driven Medicine
Tarik Dlala, VP Marketing, Sophia Genetics
15 June 2018 · 12:14 p.m.
Ada inside
Vincent Zimmer, Ada Health, Berlin
15 June 2018 · 12:39 p.m.
biospectal, the optical revolution in hypertension monitoring
Prof. Patrick Schoettker, CMO. Biospectal
15 June 2018 · 2:06 p.m.
3D Printed Medicines: A Digital Pharmacy Era
Sarah Trenfield, MPharm, Senior Formulation Scientist, FabRx Ltd.
15 June 2018 · 2:23 p.m.
The Digipharm experience
Ahmed Abdullah, CEO & co-founder, Digipharm, Basel
15 June 2018 · 2:45 p.m.
Enabling the rehabilitative revolution
Dr. Manfredo Atzori, HES-SO Valais Wallis
15 June 2018 · 3 p.m.
Team Gamified Multi-sensory Stroke Rehab
Jean-Luc Turlan et J-P. Ghobril, Lauréats Arkathon 2018
15 June 2018 · 3:22 p.m.
Secure and Trustable EMR Sharing using Blockchain: Open Challenges and Lessons Learned
Alevtina Dubovitskaya, HES-SO Valais-Wallis
15 June 2018 · 3:38 p.m.
Conclusions
Sébastien Mabillard, CEO | Swiss Digital Health
15 June 2018 · 3:59 p.m.

Recommended talks

La vision d’Agfa HealthCare, France
Jörg Schwarz, Global Business Development, Agfa HealthCare
6 June 2014 · 10:23 a.m.